DB-1303, a HER2-targeting ADC, for patients with advanced/metastatic endometrial cancer: Preliminary clinical results from an ongoing phase 1/2A Trial (NCT05150691) Meeting Abstract
| Authors: | Moore, K.; Makker, V.; Yeku, O.; Pothuri, B.; Growden, W.; Hamilton, E.; Musa, F.; Wang, L.; Li, X.; Godbee, N.; Shen, W.; Liu, L.; Shi, R.; Liu, S.; Gu, W.; Qiu, Y.; Zhu, Z. |
| Abstract Title: | DB-1303, a HER2-targeting ADC, for patients with advanced/metastatic endometrial cancer: Preliminary clinical results from an ongoing phase 1/2A Trial (NCT05150691) |
| Meeting Title: | 2023 International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 33 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2023 Sep 28-Oct 1 |
| Meeting Location: | Istanbul, Turkey |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-09-01 |
| Start Page: | A9 |
| End Page: | A10 |
| Language: | English |
| ACCESSION: | WOS:001264297900015 |
| DOI: | 10.1136/ijgc-2023-ESGO.14 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 430 -- Source: Wos |
